Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,204
Closed -$300K 114
2021
Q1
$300K Sell
1,204
-27
-2% -$6.44K 0.07% 99
2020
Q4
$283K Sell
1,231
-4
-0.3% -$922 0.07% 91
2020
Q3
$314K Buy
1,235
+97
+9% +$24K 0.09% 76
2020
Q2
$268K Buy
1,138
+267
+31% +$60.9K 0.06% 83
2020
Q1
$177K Sell
871
-27
-3% -$5.9K 0.05% 81
2019
Q4
$216K Buy
898
+29
+3% +$6.39K 0.05% 85
2019
Q3
$168K Buy
869
+33
+4% +$6.33K 0.05% 89
2019
Q2
$154K Buy
836
+34
+4% +$6.09K 0.04% 88
2019
Q1
$152K Buy
802
+28
+4% +$5.35K 0.05% 83
2018
Q4
$151K Sell
774
-18
-2% -$3.51K 0.06% 82
2018
Q3
$164K Sell
792
-48
-6% -$9.46K 0.05% 79
2018
Q2
$155K Buy
840
+9
+1% +$1.59K 0.06% 77
2018
Q1
$142K Sell
831
-1
-0.1% -$184 0.06% 73
2017
Q4
$145K Buy
832
+3
+0.4% +$531 0.07% 69
2017
Q3
$155K Buy
829
+25
+3% +$4.43K 0.08% 64
2017
Q2
$138K Sell
804
-62
-7% -$10.1K 0.08% 55
2017
Q1
$142K Sell
866
-36
-4% -$5.98K 0.09% 52
2016
Q4
$132K Buy
+902
New +$136K 0.1% 51

Other funds holding AMGN

Heck Capital Advisors's AMGN Position: Q2 2021 in Review

Heck Capital Advisors sold out of Amgen (AMGN) in Q2 2021, closing a stake of 1,204 shares — an estimated $300K sold.

Heck Capital Advisors first reported a position in AMGN in Q4 2016 and held it in 18 quarters. The position peaked at $314K in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Heck Capital Advisors reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Heck Capital Advisors sold 1,204 Amgen shares in Q2 2021, an estimated $300K.
  • Heck Capital Advisors first reported a position in Amgen in Q4 2016 and held it in 18 quarters.
  • Heck Capital Advisors's Amgen position peaked at $314K in Q3 2020.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Heck Capital Advisors's 13F filing for Q2 2021, filed 19 May 2025.